Abstract

The patent application for Viread, an AIDS drug, was opposed HIV/AIDS patient groups with the main concern, the drug, if patented, would not be affordable to most AIDS patients. Humanitarian organizations like Medecins Sans Frontieres (MSF) have supported the opposition to the patent.

Learning Objectives

The case is structured to achieve the following Learning Objectives:

• 0

Keywords

Aids Drugs, Patent, Gilead Sciences Inc, Gilead, Viread, pre-grant opposition, patent application, UNAIDS, Medecins Sans Frontieres, MSF, healthcare, manufacturing, marketing, domestic manufacturers, patented drugs, MSF